Skip to content

Author

P. O. Fernandes

We have 2 of 10 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Bend and Snap: Computationally Exploring the Helix Bias for Classifying Abl Kinase Allosteric Modulators

Allosteric modulation of Abl kinase via its myristoyl binding pocket is a promising strategy for drug discovery, either aiming at inhibition to treat Chronic Myeloid Leukemia, or activation, under investigation for breast cancer therapy. Although activators and inhibitors can be differentiated by the induced α-helix-I conformation, in silico classification has been proven challenging. Our study distinguishes these classes effectively by integrating multiple computational approaches that account for the conformational plasticity of the regulatory α-helix-I. By evaluating traditional molecular docking, co-folding, and molecular dynamics simulations with methodology benchmarking, we use these methods to uncover mechanistic principles of allosteric modulation. Docking highlighted potentially stabilizing C–F interactions with deep-pocket residues, while co-folding correctly predicted helix bending for inhibitors and outperformed docking in virtual screening. Molecular dynamics revealed that the α-helix-I samples multiple possible conformations and uncovered motions consistent with dynamic coupling between helix bending and long-range restraint of the activation loop, a nuanced mechanism that static models could not elucidate. This study provides a validated framework that combines efficient classification with mechanistic analysis by combining molecular docking, co-folding, and molecular dynamics. Our approach aids in identifying myristoyl pocket ligands, differentiating inhibitors from activators, and suggesting allosteric principles that govern their function, paving the way for more rational design of next-generation, function-specific Abl modulators.

P. T. T. F. Leite, P. O. Fernandes, D. M. Martins et al. · 0 citations
Open access Jul 2026

Underexplored Ligand‐Binding Features of FabI From Staphylococcus aureus and Escherichia coli: A Comparative Pharmacophoric Modeling and Surface Mapping Approach

The rapid spread of antimicrobial resistance, particularly among pathogens such as Staphylococcus aureus and Escherichia coli, highlights the urgent need for novel antibacterial agents with new mechanisms of action. The bacterial enoyl‐acyl carrier protein reductase (FabI), an essential enzyme in fatty acid biosynthesis, represents a promising target for narrow‐spectrum antimicrobials. This study aimed to define consensus pharmacophore models and interaction profiles for FabI through an integrated computational approach. ConPhar and FTMap analyses were applied to experimental structures and molecular dynamics (MD) simulations, while protein–ligand interactions from crystallographic complexes were evaluated using PLIP. Results revealed a conserved binding core involving residues Y156/Y157 and A95 in both species. We also assessed the reliability of residues located in flexible regions by comparing MD snapshots and experimental structures, as well as the contribution of inhibitor–cofactor interactions. Surface mapping identified Y146/Y147 as a key residue, consistent with its reported role in resistance mutations. Additionally, residues I200 (E. coli), V201 (S. aureus), and F203/F204 were identified as potential unexplored interaction sites. Finally, validated consensus pharmacophore models were proposed for future virtual screening and inhibitor design.

P. T. T. F. Leite, Lucas H S Ocarino, G. Veríssimo et al. · 0 citations